UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014-04, Vol.17 (2), p.213-225

2014

Link zum Volltext

Verfügbarkeit prüfen

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer

Oncotarget, 2018-04, Vol.9 (27), p.18698-18711

2018

Link zum Volltext

Verfügbarkeit prüfen

Claudin18.2 in Advanced Gastric Cancer

Cancers, 2023-12, Vol.15 (24), p.5742

2023

Link zum Volltext

Verfügbarkeit prüfen

Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer

Journal of gastroenterology, 2009-07, Vol.44 (7), p.685-690

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of alpelisib (BYL719), an α‐specific PI3K inhibitor, in Japanese patients with advanced solid tumors

Cancer science, 2019-03, Vol.110 (3), p.1021-1031

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors

Cancer science, 2018-01, Vol.109 (1), p.193-198

2018

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer

Clinical cancer research, 2018-08, Vol.24 (16), p.3867-3877

2018

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017-07, Vol.20 (4), p.655-662

2017

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer

Molecular cancer, 2019-02, Vol.18 (1), p.19-19, Article 19

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients

European journal of clinical pharmacology, 2018-11, Vol.74 (11), p.1461-1469

2018

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer

Journal of clinical oncology, 2010-04, Vol.28 (11), p.1904-1910

2010

Link zum Volltext

Verfügbarkeit prüfen

Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer

Journal of cancer research and clinical oncology, 2016-08, Vol.142 (8), p.1727-1738

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

Investigational new drugs, 2015-06, Vol.33 (3), p.740-750

2015

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

Annals of surgery, 2019-05, Vol.269 (5), p.879

2019

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer

Cancer science, 2015-12, Vol.106 (12), p.1722-1729

2015

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma

International journal of cancer, 2019-03, Vol.144 (5), p.1160-1169

2019

Link zum Volltext

Verfügbarkeit prüfen

microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer

BMC cancer, 2017-11, Vol.17 (1), p.723-723, Article 723

2017

Link zum Volltext

Verfügbarkeit prüfen

FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth

Cancer research (Chicago, Ill.), 2010-03, Vol.70 (5), p.2053-2063

2010

Link zum Volltext

Verfügbarkeit prüfen

A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation

Therapeutic drug monitoring, 2020-06, Vol.42 (3), p.503

2020

Link zum Volltext

Verfügbarkeit prüfen

Promotion of the Warburg effect is associated with poor benefit from adjuvant chemotherapy in colorectal cancer

Cancer science, 2020-02, Vol.111 (2), p.658-666

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 602

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(506)
Mit Volltextzugriff
(566)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(327)
Life Sciences & Biomedicine
(303)
Humans
(297)
Male
(243)
Female
(227)
Oncology
(204)
Middle Aged
(192)
Aged
(184)
Adult
(174)
Biological And Medical Sciences
(102)
Medical Sciences
(98)
Cancer Research
(86)
Medicine
(81)
Tumors
(80)
Treatment Outcome
(77)
Medicine & Public Health
(75)
Chemotherapy
(63)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(59)
Colorectal Cancer
(57)
Pharmacology & Pharmacy
(55)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF -Mutant Melanoma

Circulating exosomal microRNAs as biomarkers of colon cancer

Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Optimal chemotherapy for advanced gastric cancer: is there a global consensus?

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer

Claudin18.2 in Advanced Gastric Cancer

Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer

Phase I study of alpelisib (BYL719), an α‐specific PI3K inhibitor, in Japanese patients with advanced solid tumors

Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer

Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer

Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients

Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer

Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer

A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma

microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer

FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth

A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation

Promotion of the Warburg effect is associated with poor benefit from adjuvant chemotherapy in colorectal cancer

Suchergebnisse filtern